secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-09-27T23:59:59+00:00
Accession:  0001193125-23-243082
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex to present ActivMAb platform and pepinemab PDAC study at two conferences
--------------------------------------------------------------------------------

- Presentation at CHI's DOT Conference on Sept 28: new ActivMAb application for multi-pass membrane proteins including CXCR5.
- Poster on Phase 1b/2a pepinemab + avelumab in chemotherapy-refractory metastatic PDAC at AACR Pancreatic Cancer conference on Sept 29.
- Dr. Ernest Smith to present at DOT; Dr. Luis Ruffolo of University of Rochester presents the PDAC poster.
- Poster will be available on Vaccinex website under 'Investors/Presentations' starting Sept 27 at 5:30 pm ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523243082/0001193125-23-243082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523243082/d483793d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-243082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer